| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
OrthoPediatrics Corp.$20.45
+0.5 (+2.51%)
Market Cap
471.83 M
EPS
-1.68
P/E Ratio
-
Value Trade
3.20 M
SEC Financials
Q1 2026Dilution Risk
Revenue
59.36 M
R&D Expenses
2.23 M
Operating CF
-3.29 M
Total Assets
502.19 M
Total Liabilities
163.48 M
Equity
338.71 M
D/E Ratio
12,345
3.2 %
Week
12.63 %
1 Month
8.12 %
3 Month
8.44 %
6 Month
-67.59 %
5 Year
2.06 %
All Time
Cash Data
Cash Position
48.81 M
Monthly Burn
1.10 M
Runway
42.4 mo
Burn Trend
SEC Filing
May 1, 2026
Overview
Volume
141.43 K
52 Week Range
14.42 - 23.70
% held by Insiders
33.55 %
% held by Institutions
64.26 %
Enterprise Value
527.25 M
Total Shares
25.67 M
Short %
4.97 %
Float Shares
17.30 M
Company Description
locked
Upcoming Catalyst
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in KIDS
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
KIDS Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-10-16 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-10-16 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-10-16 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
KIDSOSSIO Inc.’s Distribution Deal With OrthoPediatrics Corp. Brings Bio-Integrative, Metal-Free OSSIOfiber® Implants to U.S. Children’s Hospitals Nationwide
OSSIO Inc. has entered a distribution agreement with OrthoPediatrics Corp. to provide OSSIOfiber® implants to children's hospitals across the U.S. This partnership aims to improve pediatric orthopedic care with innovative, metal-free solutions. The bio-integrative nature of OSSIOfiber® is expected to enhance patient outcomes.
Read more →KIDSOrthoPediatrics Announces Distribution Agreement with OSSIO, Inc. to Provide Revolutionary Orthopedic Fixation Technology to U.S. Children’s Hospitals Nationwide
OrthoPediatrics Corp. has entered an exclusive distribution agreement with OSSIO, Inc. to provide a bio-integrative, metal-free fixation technology for pediatric patients. This innovative technology aims to reduce the need for secondary surgeries associated with metal implants. OSSIOfiber implants integrate with the patient's bone, enhancing healing and minimizing complications. The partnership is expected to strengthen OrthoPediatrics' market position and address more pediatric orthopedic needs.
Read more →KIDSUNFO and OrthoPediatrics Partner to Bring Non-Invasive Foot Brace for Newborns to U.S. Market
UNFOMed Ltd. has partnered with OrthoPediatrics to introduce the UNFO foot brace for Metatarsus Adductus in the U.S. This FDA-approved device offers a non-invasive alternative to painful casting and surgery, significantly improving the treatment experience for newborns. Developed by Dr. Izak Daizade, the brace has shown a 95% success rate in clinical use.
Read more →KIDSOrthoPediatrics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
OrthoPediatrics Corp. announced its participation in the Goldman Sachs 47th Annual Global Healthcare Conference. Fred Hite, the COO and CFO, will engage in a fireside chat on June 8, 2026. The event will be accessible via an audio webcast on the company's investor relations website, with a replay available post-event.
Read more →KIDSOrthoPediatrics Corp. Reports First Quarter 2026 Financial Results and Increases 2026 Financial Guidance
OrthoPediatrics Corp. reported a strong first quarter for 2026, with total revenue reaching $59.4 million, marking a 13% increase from the previous year. The company recorded improvements in adjusted EBITDA and free cash flow, alongside increases in both domestic and international revenue. Despite the growth, OrthoPediatrics still faced a net loss of $10.7 million, the same as the prior year. The company has raised its full year revenue guidance, reflecting confidence in continued business expansion.
Read more →KIDSOrthoPediatrics Expands Specialty Bracing Portfolio with TRAXIO Halo Gravity Traction System
OrthoPediatrics Corp. has launched the TRAXIO Halo Gravity Traction System, expanding its Specialty Bracing portfolio. This product is designed for controlled spinal realignment in pediatric patients, utilizing a weight-and-pulley mechanism within hospital settings. The system aims to enhance safety and provide a continuum of care for scoliosis treatment. The collaboration with Synetik Group strengthens OrthoPediatrics' commitment to advancing pediatric orthopedic solutions.
Read more →KIDSOrthoPediatrics Corp. to Report First Quarter Financial Results on April 30, 2026
OrthoPediatrics Corp. has announced the release date for its first quarter 2026 financial results, set for April 30, 2026, after market close. The company will hold a conference call at 4:30 p.m. ET on the same day to discuss these results. Investors can access the call via a live and archived webcast on the company's website.
Read more →KIDSOrthoPediatrics to Participate in the 25th Annual Needham Virtual Healthcare Conference
OrthoPediatrics Corp. will participate in the 25th Annual Needham Virtual Healthcare Conference. CEO Dave Bailey and CFO Fred Hite are scheduled for a fireside chat on April 14, 2026, at 9:30 am ET. An audio webcast will be available on the company's investor relations website, with a replay offered post-event.
Read more →KIDSOrthoPediatrics to Participate in Upcoming Conferences
OrthoPediatrics Corp. (KIDS) announced its participation in two upcoming investor conferences, including the TD Cowen 46th Annual Health Care Conference and The Citizens Life Sciences Conference. The events will feature fireside chats, with webcasts available for those unable to attend live. The company continues to focus on pediatric orthopedics, offering over 85 products.
Read more →KIDSOrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2025 Financial Results
OrthoPediatrics Corp. reported strong financial results for the fourth quarter and full year 2025, achieving a record revenue of $236.3 million, a 15% increase compared to 2024. The company generated its first positive free cash flow in history during Q4, amounting to $10 million. Despite a net loss of $39.6 million, up slightly from 2024, management reiterated confidence in growth, projecting 2026 revenues to increase by 11% to 13%. The company also highlighted the support of over 37,500 children in the latest quarter, emphasizing its commitment to pediatric orthopedics.
Read more →KIDSOrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
OrthoPediatrics Corp. has announced that it will release its financial results for the fourth quarter and full year of 2025 on February 26, 2026, following the market close. A conference call to discuss these results is scheduled for the same day at 4:30 p.m. ET. The company, which focuses exclusively on pediatric orthopedics, offers a wide array of products aimed at improving the lives of children with orthopedic conditions.
Read more →KIDSOrthoPediatrics Announces Expanded Enabling Technology Market Opportunity
OrthoPediatrics Corp. announced that its partner iotaMotion received FDA 510(k) clearance for the iotaSOFT Insertion System, now approved for children aged four and older. This robotic-assisted technology aims to improve cochlear implant surgeries by reducing variability. Cincinnati Children's Hospital is the first pediatric center to adopt this system, enhancing care for young patients.
Read more →KIDSOrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2025 and Issues 2026 Financial Guidance
OrthoPediatrics Corp. announced record preliminary unaudited revenue of $236.1 million for the full year 2025, representing a 15% increase from 2024. The company also provided optimistic financial guidance for 2026, projecting revenues between $262 million to $266 million. The business has successfully helped over 37,500 children in the fourth quarter alone, indicating a significant impact in pediatric orthopedics. Challenges remain as their forward-looking statements acknowledge potential risks that could affect future performance.
Read more →KIDSOrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Product Launches
OrthoPediatrics Corp. has expanded its Specialty Bracing portfolio with the launch of two new products, the PediHip™ Rigid Brace and PediHip™ Modular Abduction Systems. These products are designed for treating Developmental Dysplasia of the Hip (DDH) in children aged three years and younger. The new additions bring the total to 31 systems in the OPSB division, enhancing treatment options for pediatric patients.
Read more →KIDSOrthoPediatrics Corp. Reports Third Quarter 2025 Financial Results
OrthoPediatrics Corp. reported a strong third quarter for 2025, with total revenue rising to $61.2 million, a 12% increase from the previous year. Despite challenges in Latin and South America, the company remains optimistic about its growth strategy and aims for free cash flow break-even by 2026. However, net losses have widened, reflecting ongoing restructuring efforts and asset impairments.
Read more →KIDSOrthoPediatrics Corp. Receives FDA approval for 3P™ Pediatric Plating Platform™ Small-Mini System, the second of several systems in the 3P family
OrthoPediatrics Corp. has received FDA approval for its 3P Pediatric Plating Platform Small-Mini System, marking the company's sixth approval in 2025. This system is designed for pediatric orthopedic surgeries and features variable-angle locking implants. The approval follows the successful launch of the 3P Hip System and aims to enhance surgical efficiency. A limited market release is expected in early 2026.
Read more →KIDSOrthoPediatrics Corp. to Report Third Quarter Financial Results on October 28, 2025
OrthoPediatrics Corp. has announced the date for its third quarter 2025 financial results, which will be released on October 28, 2025, following market close. Alongside the financial report, the company will hold a conference call at 4:30 p.m. ET to discuss the outcomes. OrthoPediatrics focuses on pediatric orthopedics and offers a wide range of products aimed at improving the lives of children with orthopedic conditions.
Read more →KIDSOrthoPediatrics Corp. Announces Preliminary Third Quarter 2025 Revenue and Revised 2025 Guidance
OrthoPediatrics Corp. has announced preliminary financial results for Q3 2025, revealing a revenue expectation of $233.5 million to $234.5 million, down from earlier guidance. The company cited challenges including delayed capital sales and difficulties in forecasting order timing, particularly in Latin America. Despite these setbacks, OrthoPediatrics remains committed to revenue growth and achieving cash flow break-even by 2026.
Read more →KIDSOrthoPediatrics Corp. Completes First Procedures with VerteGlide™ Spinal Growth Guidance System
OrthoPediatrics Corp. has successfully completed the first U.S. surgical procedures using its VerteGlide Spinal Growth Guidance System, designed for treating Early Onset Scoliosis (EOS). Surgeons involved reported great success, highlighting the system's potential to address a significant clinical need. VerteGlide will also be showcased at upcoming medical conferences, emphasizing its innovative technology.
Read more →KIDSOrthoPediatrics Corp. Announces Distribution Agreement with MY01 Inc.
OrthoPediatrics Corp. has announced a distribution agreement with MY01 Inc. to enhance the diagnosis of limb perfusion injuries in pediatric patients. This partnership aims to provide access to MY01's Continuous Perfusion Sensing Technology, which is crucial for identifying acute compartment syndrome in children. The collaboration emphasizes the importance of timely intervention to prevent severe complications.
Read more →KIDSOrthoPediatrics Corp. Announces the Appointment of Kelly Fischer to its Board of Directors
OrthoPediatrics Corp. has appointed Kelly Fischer to its Board of Directors, effective August 8, 2025. This appointment coincides with the retirement of Terry Schlotterback, who served for over fifteen years. Fischer, currently CFO at Cook Medical, aims to leverage her experience to enhance the company's strategy and market share in pediatric orthopedics.
Read more →KIDSOrthoPediatrics Corp. Reports Second Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance
OrthoPediatrics Corp. reported strong financial results for the second quarter of 2025, achieving a record total revenue of $61.1 million and increasing its full-year revenue guidance. The company saw notable growth in its Scoliosis and Trauma revenue segments, with a 35% increase in Scoliosis revenue compared to the previous year. However, the net loss rose to $7.1 million, reflecting increased operating expenses. OrthoPediatrics continues to expand its operations and product offerings, reinforcing a positive outlook for future growth.
Read more →KIDSOrthoPediatrics Corp. Announces Continued Expansion of Specialty Bracing Division Into New Territories with Multiple Clinics
OrthoPediatrics Corp. has announced the expansion of its Specialty Bracing division into new territories, launching multiple clinics in California, Ohio, and Colorado. This growth includes the company's first clinic in California's Los Angeles market, which offers access to a large patient population. Additionally, the expansion features new operations in New York and Ireland, with the latter marking OrthoPediatrics’ first international market. The company aims to enhance access to pediatric orthopedic care and has received enthusiastic support from healthcare professionals.
Read more →KIDSOrthoPediatrics Corp. to Participate in the 45th Canaccord Genuity Annual Growth Conference
OrthoPediatrics Corp. has announced its participation in the 45th Canaccord Genuity Annual Growth Conference, scheduled for August 13, 2025, in Boston, MA. The company's President and CEO, Dave Bailey, along with COO and CFO Fred Hite, will partake in a fireside chat. An audio webcast of the discussion will be available on their investor relations website. OrthoPediatrics, established in 2006, specializes in pediatric orthopedics and offers over 80 products to enhance the treatment of children with orthopedic conditions.
Read more →KIDSOrthoPediatrics Corp. Launches 3P™ Pediatric Plating Platform™ Hip System and Completes First Case
OrthoPediatrics Corp. has announced the US launch of its 3P Pediatric Plating Platform Hip System, designed for treating proximal femur fractures and deformities. The initial surgical case using this system has been successfully completed, receiving positive feedback from surgeons. The product is positioned to enhance pediatric orthopedic surgery with advanced technology and a comprehensive range of sizes. Following the launch, significant interest in the system has resulted in multiple bookings for surgical procedures in August.
Read more →KIDSOrthoPediatrics Corp. to Report Second Quarter Financial Results on August 5, 2025
OrthoPediatrics Corp. has announced its plan to report second quarter financial results on August 5, 2025, following the market's close. The company will also host a conference call on the same day at 4:30 p.m. ET to discuss these results in detail. The corporation, specializing in pediatric orthopedics, has a strong product portfolio and operates in multiple countries. This announcement reflects the company's ongoing commitment to its operations and investor relations.
Read more →KIDSOrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annual Meeting
OrthoPediatrics Corp. has announced its ongoing support as an Emerald Sponsor for the 2025 Pediatric Orthopaedic Society of North America (POSNA) annual meeting. The company will showcase its portfolio of pediatric-specific solutions, including the OrthoPediatrics Specialty Bracing and Enabling Technologies. President and CEO David Bailey emphasized the company's commitment to advancing pediatric orthopedics and enhancing children's lives through educational initiatives and partnerships at the meeting.
Read more →KIDSOrthoPediatrics Corp. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance
OrthoPediatrics Corp. has reported its financial results for the first quarter of 2025, revealing total revenue of $52.4 million, a 17% increase from the same period in the previous year. The company also achieved significant growth in its Trauma and Deformity and Scoliosis product lines, with increases of 14% and 34% respectively. However, the net loss increased to $10.7 million, albeit with a slight improvement in adjusted EBITDA loss compared to the prior year. The company has raised its full-year revenue guidance, anticipating total revenue between $236 million and $242 million.
Read more →KIDSOrthoPediatrics Corp. Expands Trauma and Deformity Portfolio with 3P™ Pediatric Plating Platform™ Hip System
OrthoPediatrics Corp. has announced the expansion of its Trauma and Deformity portfolio with the introduction of the 3P Pediatric Plating Platform Hip System, marking its fifth FDA approval in 2025. This innovative system aims to modernize trauma and deformity correction in pediatric orthopedic care. The company plans to follow with additional systems, enhancing their product offerings and improving surgical workflows. This launch is expected to significantly transform OrthoPediatrics' plate and screw product portfolio, establishing them as a leader in pediatric orthopedics.
Read more →KIDSOrthoPediatrics Corp. to Report First Quarter Financial Results on May 7, 2025
OrthoPediatrics Corp. has announced the scheduling of its first quarter financial results for 2025, which will be released on May 7, 2025, after market close. The company will host a conference call the same day at 4:30 p.m. ET to discuss these results. OrthoPediatrics, founded in 2006, specializes in pediatric orthopedics and operates globally across more than 70 countries with a comprehensive product range for various orthopedic conditions in children.
Read more →KIDSOrthoPediatrics Corp. Expands Scoliosis Portfolio with Launch of VerteGlide™ System
OrthoPediatrics Corp. has launched the VerteGlide Spinal Growth Guidance System to treat Early Onset Scoliosis in children under 10. This new system aims to correct deformities while reducing the need for repeated surgeries until the child reaches skeletal maturity. With FDA clearance received, the company plans a limited launch and initial surgeries in specific children's centers by summer 2025. This development represents OrthoPediatrics' ongoing commitment to advancing pediatric orthopedic care.
Read more →KIDSOrthoPediatrics Corp. to Participate in the 24th Annual Needham Virtual Healthcare Conference
OrthoPediatrics Corp. is set to participate in the 24th Annual Needham Virtual Healthcare Conference on April 8, 2025. The company's CEO Dave Bailey and CFO Fred Hite will lead a fireside chat during the event, which will be available for live and recorded listening on their investor relations website. OrthoPediatrics focuses on developing products for pediatric orthopedic conditions and currently markets over 75 products in various categories.
Read more →KIDSOrthoPediatrics Corp. Named One the 2025 Best Places to Work in Indiana
OrthoPediatrics Corp. has been named one of the 2025 Best Places to Work in Indiana by the Indiana Chamber of Commerce, marking the 9th time it has received this accolade. The company emphasizes its dedication to creating an engaging workplace and meaningful career experiences. This recognition is part of a statewide initiative that identifies leading workplace cultures across various industries. Final rankings will be announced at an awards ceremony on April 30th, 2025.
Read more →KIDSOrthoPediatrics Corp. Joins Crossroads Pediatric Device Consortium to Advance Pediatric Medical Device Innovation
OrthoPediatrics Corp. has announced its partnership with the Crossroads Pediatric Device Consortium (CPDC) to enhance pediatric medical device innovation. This collaboration aims to accelerate the development and commercialization of specialized medical devices for children, leveraging expertise from key institutions including Purdue University and Cook Medical. The consortium is designed to integrate industry leaders to streamline the regulatory and commercialization process for pediatric medical technologies. OrthoPediatrics' association with CPDC is expected to advance healthcare solutions specifically for pediatric patients.
Read more →KIDSOrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results
OrthoPediatrics Corp. has reported record financial results for the fourth quarter and full year 2024, achieving a total revenue of $204.7 million, a 38% increase compared to the previous year. The company helped over 138,000 children during the year and significantly improved its adjusted EBITDA to $8.5 million. However, OrthoPediatrics also incurred a net loss of $37.8 million, increasing from a loss of $21 million in 2023. Expectations for 2025 include further revenue growth, with guidance set between $235 million and $242 million.
Read more →KIDSOrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
OrthoPediatrics Corp. announced that it will report its fourth quarter and full year 2024 financial results on March 4, 2025. Following the release, the company will host a conference call to discuss the results. The firm specializes in pediatric orthopedics and has a diverse range of over 75 products for various orthopedic conditions, expanding its impact on child healthcare.
Read more →KIDSOrthoPediatrics Corp. Announces Distribution Agreement with Thrive Orthopedics LLC
OrthoPediatrics Corp. has secured a distribution agreement with Thrive Orthopedics LLC to enhance its range of pediatric orthopedic solutions. This partnership will allow OrthoPediatrics to introduce three innovative bracing products, including a lightweight carbon fiber ankle foot orthosis and an above-the-knee bracing solution. The agreement marks a significant step for OrthoPediatrics as it aims to expand its reach and impact in the pediatric orthopedic field, ultimately improving care for children facing mobility challenges. Joe Hauser emphasized the excitement and growth potential this collaboration brings to the company.
Read more →KIDSOrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2024 and Issues 2025 Financial Guidance
OrthoPediatrics Corp. (Nasdaq: KIDS) announced record preliminary unaudited revenue of $204.7 million for the full year 2024, marking a 38% increase year-over-year. The company provided optimistic financial guidance for 2025, projecting revenue between $235 million and $242 million, alongside anticipated adjusted EBITDA between $15 million to $17 million. Throughout 2024, OrthoPediatrics effectively advanced its strategic initiatives and expanded its market share within pediatric orthopedics. The company's strong performance in its Trauma and Scoliosis segments is expected to continue contributing to growth.
Read more →KIDSOrthoPediatrics Corp. Announces Expansion of Specialty Bracing Division
OrthoPediatrics Corp. has announced a significant expansion of its Specialty Bracing (OPSB) division, entering three new markets in Indiana, Colorado, and Florida. The initiative aims to provide non-operative solutions for pediatric orthopedic care through both the establishment of new clinics and acquisitions. The new Indianapolis clinic is expected to support local children, while the acquisitions in Colorado and Florida will facilitate further growth in those regions. The company's CEO highlighted the positive impact this expansion holds for both the business and the community it serves.
Read more →KIDSOrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Products
OrthoPediatrics Corp. has announced the expansion of its Specialty Bracing division with the launch of two new products: the OPSB Sensor System and the MOVE-D brace. The OPSB Sensor System, a pioneering sensor solution, aims to improve brace wear compliance by utilizing Bluetooth technology for remote monitoring. Meanwhile, the MOVE-D brace is designed to assist pediatric patients with movement disorders in performing daily activities more effectively. These developments indicate OrthoPediatrics' dedication to advancing pediatric orthopedic solutions and improving patient care.
Read more →KIDSOrthoPediatrics Corp. to Host Educational and Networking Events at 20th Annual International Pediatric Orthopaedic Symposium (IPOS)
OrthoPediatrics Corp. will host educational and networking events at the 20th Annual International Pediatric Orthopaedic Symposium (IPOS) from December 3-7, 2024, in Orlando, Florida. As an Emerald-Level sponsor, the company aims to share its innovative products and engage with over 500 attending pediatric orthopedic surgeons. Key presentations will include topics on advanced surgical techniques and new materials for pediatric care. This initiative reflects OrthoPediatrics' commitment to furthering the field of pediatric orthopedics and supporting the professional development of younger practitioners.
Read more →KIDSOrthoPediatrics Corp. Expands Specialty Bracing Portfolio with DF2 Brace
OrthoPediatrics Corp. announced updates to the DF2 Brace, which now includes expanded indications for use, enhanced sizing options, and a launch in international markets such as Europe and Asia-Pacific. The updated indications allow for post-operative stabilization in addition to femur fracture fixation. With the goal of improving pediatric orthopedic care, the company expresses confidence in the DF2 Brace's potential to enhance patient outcomes globally. OrthoPediatrics continues to focus on innovation within pediatric orthopedics.
Read more →KIDSOrthoPediatrics Corp. to Participate in Upcoming Conferences
OrthoPediatrics Corp. will engage in investor discussions at two upcoming conferences in New York. CEO Dave Bailey is scheduled for a fireside chat at the Stifel 2024 Healthcare Conference on November 19, 2024, and at the Piper Sandler 36th Annual Healthcare Conference on December 3, 2024. The events are part of the company's ongoing efforts to enhance communication with investors about their pediatric orthopedic advancements.
Read more →KIDSOrthoPediatrics Corp. Reports Third Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance
OrthoPediatrics Corp. has reported its third-quarter financial results for 2024, revealing significant growth in revenue and patient impact compared to the prior year. The company achieved a record revenue of $54.6 million, a 37% increase year-over-year, and increased its full-year revenue guidance to between $202 million and $204 million. However, it also reported a net loss of $7.9 million, which is an increment from the previous year's loss, primarily due to increased operating expenses and a decline in gross profit margin. The firm is optimistic about its strategies and market position in pediatric orthopedics moving forward.
Read more →KIDSOrthoPediatrics Corp. to Report Third Quarter 2024 Financial Results on November 7, 2024
OrthoPediatrics Corp. announced it will release its third quarter financial results on November 6, 2024, after market close. A conference call to discuss these results is scheduled for November 7, 2024, at 8:00 a.m. ET. The company, dedicated to pediatric orthopedics, has a wide range of products targeted at improving children's orthopedic conditions.
Read more →KIDSOrthoPediatrics Corp. Announces Launch of Enabling Technologies Division
OrthoPediatrics Corp. has announced the launch of its new Enabling Technologies division, aimed at expanding its impact in pediatric orthopedics through digital health and advanced technology. This division will utilize innovations such as the 7D Flash Navigation System and patient-specific cutting guides. Upcoming technology platforms include Playbook, which improves surgical planning and outcomes, and a robotic insertion system for cochlear implants that enhances precision for pediatric patients. The new division is expected to create sustainable revenue growth and access new markets.
Read more →KIDSOrthoPediatrics Corp. to Host Investor Day on September 12, 2024
OrthoPediatrics Corp. has announced its upcoming investor day scheduled for September 12, 2024, in New York. The event will focus on updates to the Company’s Specialty Bracing business strategy, product pipeline, and financial outlook, and will include a panel of key opinion leader surgeons. Interested investors can register to attend the event and it will also be available via live webcast.
Read more →KIDSOrthoPediatrics Corp. Announces Private Financing Term Loan and Private Placement of Convertible Notes Will Provide Up To $100 Million of Capital
OrthoPediatrics Corp. has secured a private financing deal with Braidwell LP that includes a term loan and convertible notes amounting to $100 million. This funding aims to strengthen the company's financial position and support its growth strategies, particularly in expanding clinic operations across children's hospitals. With this financing, OrthoPediatrics may reach cash flow breakeven and further enhance its market presence in pediatric orthopedics. However, the financing comes with certain financial covenants and an outstanding debt of around $10 million that the company will need to manage.
Read more →KIDSOrthoPediatrics Corp. Reports Second Quarter 2024 Financial Results and Reaffirms Full Year 2024 Revenue Guidance
OrthoPediatrics Corp. reported strong financial results for the second quarter of 2024, achieving a record revenue of $52.8 million, a 33% increase from the previous year. The company also assisted a record 32,000 children, highlighting its growth and commitment to pediatric orthopedics. Despite the positive financial performance, OrthoPediatrics experienced an increase in net loss to $6.0 million. The company reaffirmed its revenue guidance for the full year of 2024, projecting revenues between $200.0 million and $203.0 million, indicating continued growth potential.
Read more →KIDSOrthoPediatrics Corp. Announces Private Financing
OrthoPediatrics Corp. has announced a private financing arrangement with Braidwell LP, which includes a $50 million term loan and a $50 million convertible note offering. This financing aims to provide up to $100 million to strengthen the company's balance sheet and support its growth initiatives within pediatric orthopedics. The company plans to use the proceeds for debt repayment, stock repurchases, and general working capital needs. The financing is expected to fund around August 12, 2024.
Read more →KIDSOrthoPediatrics Corp. to Report Second Quarter 2024 Financial Results on August 6, 2024
OrthoPediatrics Corp. is set to announce its financial results for the second quarter of 2024 on August 5, 2024, after market close. A conference call is scheduled for August 6, 2024, at 8:00 a.m. ET to discuss these results. The company focuses on pediatric orthopedics and offers a wide range of products tailored for this field.
Read more →KIDSOrthoPediatrics Corp. to Participate in the Truist Securities MedTech Conference
OrthoPediatrics Corp. announced its participation in the Truist Securities MedTech Conference, scheduled for June 18, 2024, in Boston, MA. CEO Dave Bailey will engage in a fireside chat during the event, which will be accessible via an audio webcast. The company focuses on pediatric orthopedics and offers a wide range of products tailored to treat various orthopedic conditions in children.
Read more →KIDSOrthoPediatrics Corp. Continued Leading Sponsorship at 2024 EPOSNA Annual Meeting
OrthoPediatrics Corp. announced its ongoing sponsorship as an Emerald sponsor at the 2024 Pediatric Orthopaedic Society of North America and European Paediatric Orthopaedic Society annual meeting. The company highlighted its expanding range of pediatric-specific orthopedic solutions at the event. Additionally, it sponsored a session focused on orthopedic management decisions for neuromuscular patients, emphasizing various surgical and non-surgical treatments. OrthoPediatrics has a long-standing commitment to supporting POSNA and EPOS through educational grants and symposiums, reflecting its alignment with these organizations to improve pediatric orthopedic care.
Read more →KIDSOrthoPediatrics Corp. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance
OrthoPediatrics Corp. reported a 41% increase in total revenue for Q1 2024, reaching $44.7 million, and a 47% rise in the number of children helped. The company raised its full-year revenue guidance to between $200.0 million and $203.0 million, anticipating growth in several product lines and following the acquisition of Boston Orthotics & Prosthetics. However, the company recorded a net loss of $7.8 million in Q1 2024 and increased operating expenses by 30%. Overall, the outlook for the company is positive despite the losses reported.
Read more →KIDSOrthoPediatrics Corp. Receives “Breakthrough Device” Designation from FDA for eLLi™ Growing Rod System for Pediatric Patients with Scoliosis
OrthoPediatrics Corp. has been granted 'Breakthrough Device' designation by the FDA for its eLLi Growing Rod System, designed for pediatric patients with Early Onset Scoliosis. This designation aims to expedite the development and review process of devices intended for serious medical conditions. The eLLi system provides enhanced mechanical reliability and improved safety compared to existing technologies, presenting a new option for surgeons treating spinal deformities in children. OrthoPediatrics' CEO, David Bailey, expressed pride in the achievement and the positive impact the product will have on patients.
Read more →KIDSOrthoPediatrics Corp. to Report First Quarter 2024 Financial Results on May 7, 2024
OrthoPediatrics Corp. has scheduled its first quarter 2024 financial results announcement for May 6, 2024. Following the release, the company will host a conference call on May 7, 2024, to discuss the results. OrthoPediatrics focuses on pediatric orthopedics and has developed a wide range of products to cater to this market, enhancing the quality of care for children with orthopedic issues.
Read more →KIDSOrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 8th Annual International Children’s Spine Symposium (ICSS)
OrthoPediatrics Corp. (NASDAQ: KIDS) will participate in the 8th Annual International Children’s Spine Symposium (ICSS) on April 5th and 6th in Denver, Colorado. The company will highlight its RESPONSE™ portfolio and new Rib and Pelvic Fixation systems, both aimed at treating pediatric scoliosis. Additionally, educational grants will be provided to support medical professionals attending the event. David Bailey, the company's President & CEO, expressed pride in sponsoring the symposium, emphasizing its role in advancing pediatric orthopedic education.
Read more →KIDSOrthoPediatrics Corp. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
OrthoPediatrics Corp. (KIDS) has announced that its CEO Dave Bailey and COO Fred Hite will participate in the 23rd Annual Needham Virtual Healthcare Conference, scheduled for April 9, 2024. This event will feature a fireside chat format and aims to facilitate discussions relevant to the pediatric orthopedics sector. An audio webcast of the chat will be accessible on the company's investor relations website. OrthoPediatrics focuses exclusively on advancing pediatric orthopedic solutions and has a substantial product offering in the market.
Read more →KIDSOrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results
OrthoPediatrics Corp. has reported impressive financial results for the fourth quarter and full year 2023, including a record revenue of $148.7 million, up 22% from 2022. The company helped nearly 82,000 children in 2023 and launched several new products, bolstering its position in pediatric orthopedics. Despite a net loss of $21.0 million for the year and increases in operational expenses, management remains optimistic about future growth and has guided revenue expectations for 2024 between $197.0 million and $200.0 million. The acquisition of Boston Orthotics & Prosthetics is anticipated to support their continued expansion.
Read more →KIDSOrthoPediatrics Corp. Launches New RESPONSE Rib and Pelvic Fixation System for EOS Scoliosis
OrthoPediatrics Corp. has launched the RESPONSE Rib and Pelvic Fixation System, aimed at treating children with Early Onset Scoliosis (EOS). This system, the 71st addition to their orthopedic offerings, includes new implants and instruments for effective rib and pelvic fixation. It is designed to address the needs of patients at risk of Thoracic Insufficiency Syndrome, marking a significant expansion into the EOS treatment market. The system is compatible with existing RESPONSE systems, facilitating better treatment options for a broader range of scoliosis patients.
Read more →KIDSOrthoPediatrics Corp. Named One of the 2024 Best Places to Work in Indiana
OrthoPediatrics Corp. has been recognized as one of the 2024 Best Places to Work in Indiana, marking the eighth time the company has achieved this honor. The recognition reflects OrthoPediatrics' commitment to creating a positive and engaging workplace culture that supports its employees. The final rankings will be announced during an awards ceremony on May 8, 2024. Indiana Chamber President Vanessa Green Sinders emphasized the importance of employee feedback in fostering workplace improvement and productivity.
Read more →KIDSOrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024
OrthoPediatrics Corp. is set to report its fourth quarter and full year 2023 financial results on March 6, 2024. Following the release, the Company will host a conference call on March 7, 2024, at 8:00 a.m. ET to discuss the outcomes. OrthoPediatrics specializes in pediatric orthopedics and markets a comprehensive range of products aimed at improving children's orthopedic conditions. The Company operates globally, enhancing its presence in both the U.S. and international markets.
Read more →KIDSOrthoPediatrics Corp. Announces Acquisition of Boston Orthotics & Prosthetics Combined organizations have helped more than 1 million kids Expands Specialty Bracing Division with pediatric orthotic management business off
OrthoPediatrics Corp. has announced the acquisition of Boston Orthotics & Prosthetics, enhancing its pediatric orthotic management capabilities. This acquisition, valued at $22 million, is supported by an $80 million debt financing arrangement with MidCap Financial. Boston O&P, a leader in pediatric orthotics, aligns with OrthoPediatrics' mission to support children with orthopedic conditions. The merger is expected to expand OrthoPediatrics’ market reach and product offering, focusing on non-surgical treatment options.
Read more →KIDSOrthoPediatrics Corp. Announces Preliminary Unaudited Financial Highlights for the Fourth Quarter & Full Year 2023
OrthoPediatrics Corp. has announced preliminary unaudited net revenues of $37.6 million for Q4 2023, showing a 21% increase from the same quarter in 2022. For the full year 2023, the expected net revenue is $148.7 million, reflecting a 22% growth compared to 2022. The company anticipates 2024 revenues to reach between $197 million and $200 million, fueled by the recent acquisition of Boston O&P, which is expected to positively impact revenue and EBITDA going forward. The firm plans to release detailed financial results in March 2024.
Read more →KIDSOrthoPediatrics Corp. Announces Launch of Specialty Bracing Division
OrthoPediatrics Corp. has announced the launch of its Specialty Bracing division, enhancing its focus on pediatric orthopedics through non-surgical interventions. This new division is expected to increase the company's market potential by about $600 million. The company has been building a robust portfolio in this area since acquiring MD Orthopaedics, and has introduced products such as the DF2® Brace for femur fracture fixation. Additionally, a partnership with Ora Medical aims to distribute a new gait-trainer device designed for children with walking difficulties.
Read more →KIDSOrthoPediatrics Corp. to Host Educational and Networking Events at 19th Annual International Pediatric Orthopaedic Symposium (IPOS)
OrthoPediatrics Corp. announced its role as an Emerald-Level sponsor at the 19th Annual International Pediatric Orthopaedic Symposium (IPOS), taking place from December 5-9 in Orlando, Florida. The company will host several educational events aimed at pediatric orthopedic surgeons while showcasing its product portfolio. Over 500 surgeons are expected to attend the meeting, highlighting OrthoPediatrics' commitment to education and collaboration in improving pediatric orthopedic care.
Read more →KIDSOrthoPediatrics Corp. to Participate in Upcoming November Conferences
OrthoPediatrics Corp. (NASDAQ: KIDS) announced that its President & CEO Dave Bailey and COO Fred Hite will participate in two upcoming investor conferences in November 2023. The events include the Stifel 2023 Healthcare Conference and the Piper Sandler 35th Annual Healthcare Conference, where they will engage in fireside chats. These appearances reflect the company's ongoing commitment to engage with its investors and highlight its advancements in pediatric orthopedics.
Read more →KIDSOrthoPediatrics Corp. Reports Third Quarter 2023 Financial Results
OrthoPediatrics Corp. reported its financial results for the third quarter of 2023, highlighting a 14% revenue increase to $40.0 million compared to the same quarter in 2022. The company helped over 22,000 children this quarter, contributing to a significant total of 692,000 since its inception. While the net loss for the quarter was $4.6 million, an improvement in adjusted EBITDA to $3.6 million was noted. Additionally, the company launched several new products aimed at pediatric orthopedic treatment, maintaining a positive outlook for continued growth in revenue and EBITDA for the full year 2023.
Read more →KIDSOrthoPediatrics Corp. Enters Distribution Agreement with Ora Medical
OrthoPediatrics Corp. has announced an exclusive distribution agreement with Ora Medical to market the Levity gait trainer, designed for children with walking difficulties. This innovative device features a partial weight bearing mechanism, allowing children to engage actively with their environment. The partnership aims to leverage OrthoPediatrics' established market presence to enhance the device's distribution, ultimately benefiting children afflicted with orthopedic conditions worldwide.
Read more →KIDSOrthoPediatrics Corp. Launches MP+ Bar for Clubfoot
OrthoPediatrics Corp. has announced the limited release of its Mitchell Ponseti Plus Bar (MP+) specifically designed for children with clubfoot as part of its Specialty Bracing portfolio. This product features several innovations over the original bar launched in 2004, including patented technology for easier adjustments and custom fit. Additionally, OrthoPediatrics is developing the MP Lite boots & bar system for markets outside the U.S. The company continues to focus on unmet needs in pediatric orthopedics following its acquisition of MD Orthopaedics in 2022.
Read more →KIDSOrthoPediatrics Corp. Launches Pediatric Nailing Platform | Tibia
OrthoPediatrics Corp. has launched its new Pediatric Nailing Platform TIBIA system aimed at treating pediatric patients with fractures and deformities. The system, which recently received FDA 510(k) clearance, is part of a broader product suite designed specifically for children's orthopedic needs. Successful initial cases have demonstrated its effectiveness for a diverse range of patients, reflecting the company's commitment to addressing pediatric orthopedic challenges.
Read more →KIDSOrthoPediatrics Corp. to Report Third Quarter 2023 Financial Results on November 7, 2023
OrthoPediatrics Corp. has announced that it will report its third quarter 2023 financial results on November 6, 2023, after the market closes. A conference call to discuss these results is scheduled for November 7, 2023, at 8:00 a.m. ET. The company, which specializes in pediatric orthopedics, has developed a wide range of surgical systems intended to improve treatment for children with orthopedic conditions. Their products are marketed globally, reaching both the U.S. and over 70 other countries.
Read more →KIDSOrthoPediatrics Joins Alliance for Pediatric Device Innovation
OrthoPediatrics Corp. has announced a strategic partnership with Children's National Hospital under the Alliance for Pediatric Device Innovation (APDI) to foster the development of medical devices tailored for children. This collaboration includes notable members such as Johns Hopkins University and is supported by a nearly $7.5 million grant from the FDA to aid pediatric innovators. The partnership aims to address the unique challenges faced in pediatric medical device development, ensuring that advancements are aligned with the needs of growing children.
Read more →KIDSOrthoPediatrics Corp. Launches DF2 Brace
OrthoPediatrics Corp. has launched the DF2® Brace, a non-surgical solution for femur fracture fixation in pediatric patients aged 6 months to 5 years. This innovative brace replaces the traditional spica cast, offering improved treatment outcomes by providing immobilization and reducing the need for surgery and anesthesia. The DF2 Brace has been clinically studied, demonstrating comparable effectiveness while easing the treatment process for patients and families.
Read more →KIDSOrthoPediatrics was a Gold Level Sponsor of the Scoliosis Research Society 58th Annual Meeting
OrthoPediatrics Corp. sponsored the 58th Annual Meeting of the Scoliosis Research Society in Seattle, emphasizing its commitment to pediatric orthopedic care. The event, held from September 6-9, provided a platform for discussing advancements in spinal deformity treatment, particularly through non-fusion technologies such as ApiFix. The company also hosted a symposium on integrating new technologies into operating rooms, featuring industry experts. OrthoPediatrics continues to focus on developing solutions that cater to the unique needs of pediatric patients with scoliosis.
Read more →KIDSOrthoPediatrics Corp. to Participate at the Gilmartin Group Emerging Growth Company Showcase
OrthoPediatrics Corp. has announced its participation in the Gilmartin Group Emerging Growth Company Showcase scheduled for September 21, 2023. The event will feature a fireside chat with CEO Dave Bailey and COO Fred Hite. An audio webcast of the discussion will be accessible on the company's investor relations website, allowing stakeholders to follow the developments. OrthoPediatrics specializes in pediatric orthopedics and offers a wide range of surgical systems for various orthopedic conditions.
Read more →KIDSOrthoPediatrics Corp. Receives FDA 510(k) Clearance for Pediatric Nailing Platform | Tibia
OrthoPediatrics Corp. has received FDA 510(k) clearance for its Pediatric Nailing Platform | Tibia, expanding its product offerings to 51 unique surgical systems. This new system is designed to cater specifically to the anatomical needs of pediatric patients with fractures and deformities in the lower extremities. The PNP Tibia System features rigid cannulated nails and specialized instrumentation, aimed at enhancing surgical techniques. The company is optimistic about the growth potential of this product, which is expected to launch in the third quarter of 2023.
Read more →KIDSOrthoPediatrics Corp. Reports Second Quarter 2023 Financial Results
OrthoPediatrics Corp. reported its financial results for Q2 2023, achieving a revenue of $39.6 million, which is a 20% increase year-over-year. The company helped over 21,000 children in the quarter and reiterated its revenue guidance for the full year, projecting between $148.0 million and $151.0 million. Despite these positive indicators, OrthoPediatrics reported a net loss of $2.9 million, significantly higher than the previous year's loss. The increased operating expenses and a fair value adjustment reduced overall profitability, complicating the positive revenue growth narrative.
Read more →KIDSOrthoPediatrics Corp. to Report Second Quarter 2023 Financial Results on August 1, 2023
OrthoPediatrics Corp. has announced the release of its second quarter 2023 financial results on July 31, 2023, after market close. A conference call to discuss these results is scheduled for August 1, 2023, at 8:00 a.m. ET. The company is dedicated solely to advancing pediatric orthopedics, which includes a product range designed to assist various orthopedic conditions in children. Investors can access a live and archived webcast of the call through the company's website.
Read more →KIDSOrthoPediatrics Corp. Announces the Launch and First Case Using the GIRO™ Growth Modulation System
OrthoPediatrics Corp. has announced the limited launch of its new GIRO Growth Modulation System and the completion of its first clinical case. The GIRO system is designed to correct angular deformities and limb length discrepancies in pediatric patients using a less invasive approach. The successful case involved treating a patient's bilateral femoral anteversion, promising shorter recovery times and reduced risk of complications. This innovation marks a significant milestone for OrthoPediatrics, being its 50th system designed for pediatric orthopedic care.
Read more →KIDSOrthoPediatrics Announces Election of George Dyer, MD to its Board of Directors
OrthoPediatrics has announced the election of Dr. George Dyer to its Board of Directors during the Annual Meeting of Stockholders. Dr. Dyer brings a strong background in orthopedic surgery and is expected to contribute significantly to the company's strategic development and clinical training programs. His insights from working in upper extremity trauma reconstruction may enhance OrthoPediatrics' product offerings aimed at improving clinical outcomes for pediatric patients. The board now includes experienced directors serving three-year terms until 2026.
Read more →KIDSOrthoPediatrics Corp. Announce Launch of RESPONSE™ Power Scoliosis System
OrthoPediatrics Corp. has announced the launch of its new RESPONSE Power Scoliosis System, expanding its pediatric orthopedic portfolio to 49 systems. The Power System is designed to enhance efficiency in surgeries by facilitating easier screw insertion and reducing the physical effort required from surgeons. Endorsed by experts, this new system aims to provide significant improvements in the workflow and safety of scoliosis procedures, thus potentially benefiting both surgeons and patients.
Read more →KIDSOrthoPediatrics Corp. Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
OrthoPediatrics Corp. reported financial results for Q1 2023, highlighting substantial revenue growth of 35% year-on-year, totaling $31.6 million. The company received FDA clearances for new products and raised its revenue guidance for the full year, now expected at $148.0 million to $151.0 million. Despite the positive revenue trends, OrthoPediatrics faced a net loss of $6.8 million and a slight decrease in gross profit margin. The increase in operating expenses was attributed to recent acquisitions and necessary staffing for growth support.
Read more →KIDSOrthoPediatrics Corp. Continues Leading Sponsorship at 2023 POSNA Annual Meeting
OrthoPediatrics Corp. has reaffirmed its commitment to pediatric orthopedics by sponsoring the 2023 POSNA annual meeting in Nashville, Tennessee. The company showcased its diverse pediatric solutions and sponsored a specialized session on hip dysplasia. Additionally, it hosted a workshop on the ApiFix non-fusion technology, highlighting positive clinical outcomes. OrthoPediatrics elevated its sponsorship level to become the only Emerald Sponsor for POSNA, emphasizing its dedication to clinical education and support for the pediatric orthopedic community.
Read more →KIDSOrthoPediatrics Corp. Announces Launch of RESPONSE™ 5.5/6.0 Cannulated Screw System
OrthoPediatrics Corp. has announced the launch of its RESPONSE™ 5.5/6.0 Cannulated Screw System, enhancing its Scoliosis portfolio. This marks the company's 47th surgical system, reflecting its dedication to innovations in pediatric orthopedics. The new system aims to improve the accuracy and efficiency of screw placement in spinal surgeries, as noted by positive early feedback from surgeons. OrthoPediatrics continues to focus exclusively on pediatric orthopedic solutions, with a wide distribution network in the U.S. and over 70 countries.
Read more →KIDSOrthoPediatrics Corp. to Report First Quarter 2022 Financial Results on May 2, 2023
OrthoPediatrics Corp. is scheduled to report its first quarter 2023 financial results on May 1, 2023, following market close. The company, dedicated to pediatric orthopedics, will host a conference call on May 2, 2023, at 8:00 a.m. ET to discuss these results. Investors can access the call via a live and archived webcast on the company's website.
Read more →KIDSOrthoPediatrics Corp. to Participate at the 22nd Annual Needham Virtual Healthcare Conference
OrthoPediatrics Corp. will participate in the 22nd Annual Needham Virtual Healthcare Conference on April 17, 2023. The event will feature a fireside chat with key executives including CEO Dave Bailey and COO Fred Hite. An audio webcast of the discussion will be accessible on the company's investor relations website. Founded in 2006, OrthoPediatrics specializes in pediatric orthopedics, offering a wide range of surgical systems across various categories.
Read more →KIDSOrthoPediatrics Corp. Leading Sponsorship at Annual EPOS Meeting
OrthoPediatrics Corp. has announced its leading sponsorship at the European Pediatric Orthopaedic Society's annual meeting in Krakow, Poland. The company showcased its commitment to pediatric orthopedics by hosting an exhibit and a surgeon luncheon focused on Osteogenesis Imperfecta. The event provided a platform for expert presentations and discussions on complex surgical challenges, emphasizing the collaboration with Pega Medical and MD Orthopaedics. OrthoPediatrics continues its dedication to improving pediatric orthopedic practices worldwide.
Read more →KIDSOrthoPediatrics Corp. Named One of the 2023 Best Places to Work in Indiana
OrthoPediatrics Corp. has been named one of Indiana's Best Places to Work for the seventh time, reflecting its strong workplace culture and commitment to employee satisfaction. The company, known for advancing pediatric orthopedic care, is now classified as a 'Large Employer' due to its growth. CEO David Bailey expressed pride in this recognition, emphasizing the importance of fostering a positive work environment. The final rankings will be revealed on May 10, 2023, at an awards ceremony.
Read more →KIDSOrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2022 Financial Results
OrthoPediatrics Corp. reported a 25% increase in revenue for both the fourth quarter and full year 2022, achieving total revenues of $31.0 million and $122.3 million, respectively. The company served nearly 70,000 children in 2022 and expects continued growth with guidance suggesting revenue of over $146 million for 2023. Despite the positive revenue growth, OrthoPediatrics reported a net loss of $7.8 million in Q4 due to rising operational costs and expenses related to recent acquisitions. The strong international performance, particularly in revenue, highlights the company's expanding market presence.
Read more →KIDSOrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2022 Financial Results on March 1, 2023
OrthoPediatrics Corp. announced it will release its financial results for the fourth quarter and full year 2022 on February 28, 2023. Following the release, a conference call will be held on March 1, 2023, to discuss the results in detail. The company, which specializes in pediatric orthopedics, markets a comprehensive range of surgical systems targeted at various pediatric orthopedic conditions across the globe.
Read more →KIDSOrthoPediatrics Corp. Publishes Environmental, Social, and Governance (“ESG”) Summary Report
OrthoPediatrics Corp. has published an Environmental, Social, and Governance (ESG) summary report highlighting its commitment to improving pediatric orthopedic care. The report outlines significant achievements such as helping over 630,000 children worldwide and enhancing diversity within its leadership and workforce. Additionally, the company received recognition for its workplace culture for the sixth consecutive year and has initiated environmental reporting practices. These initiatives reflect OrthoPediatrics' dedication to ethics and meaningful impact in the pediatric orthopedic field.
Read more →KIDSOrthoPediatrics Corp. Announces Preliminary Unaudited Net Revenue for the Fourth Quarter & Full Year 2022, Provides Financial Outlook for 2023
OrthoPediatrics Corp. reported preliminary unaudited net revenue for Q4 2022, estimating $31.0 million, a 25% increase from the previous year. For the full year 2022, projected net revenue stands at $122.3 million, also a 25% growth. The company anticipates a growth in net revenue for 2023, reaching between $146.0 million to $149.0 million. However, the report noted potential impacts on performance due to surgery disruptions in children's hospitals and emphasized that the revenue figures remain preliminary and subject to adjustment.
Read more →KIDSOrthoPediatrics Corp. Establishes Direct Sales Organization in Germany
OrthoPediatrics Corp. has announced the formation of its direct sales organization in Germany, named OrthoPediatrics GmbH, which began operations on January 1, 2023. This initiative marks the company's first direct international presence, reflecting its commitment to improving pediatric orthopedic care globally. The new organization is expected to enhance relationships with surgeons and provide tailored resources for the German market, ultimately aiming for better patient outcomes. OrthoPediatrics GmbH will support educational initiatives for pediatric orthopedic surgeons in collaboration with the German Association for Pediatric Orthopedics.
Read more →KIDSOrthoPediatrics Corp. to Host Educational and Networking Events at 18th Annual International Pediatric Orthopaedic Symposium (IPOS)
WARSAW, Ind., Dec. 05, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced plans to host educational and networking events at IPOS and it
Read more →KIDSOrthoPediatrics to Participate in Upcoming November Conferences
WARSAW, Ind., Nov. 04, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fre
Read more →KIDSOrthoPediatrics Corp. Reports Third Quarter 2022 Financial Results and Updates 2022 Revenue Guidance
WARSAW, Ind., Oct. 31, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its financial results for the third quarter ended September 30
Read more →KIDSOrthoPediatrics Corp. Announces Appointment of Jimmy D. McDonald to Board of Directors
WARSAW, Ind., Oct. 20, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the appointment of Jimmy D. McDonald to its board of directors
Read more →KIDSOrthoPediatrics Corp. to Report Third Quarter 2022 Financial Results on November 1, 2022
WARSAW, Ind., Oct. 18, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its third quarter 202
Read more →KIDSOrthoPediatrics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
WARSAW, Ind., Aug. 18, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the company will present at the upcoming Inaugural Gilmartin G
Read more →KIDSOrthoPediatrics Corp. Announces Closing of its Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
WARSAW, Ind., Aug. 15, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the closing of its underwritten public offering of 1,091,250 s
Read more →KIDSOrthoPediatrics Corp. Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants
WARSAW, Ind., Aug. 11, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the pricing of its previously announced underwritten public of
Read more →KIDSOrthoPediatrics Corp. Announces Proposed Offering of Common Stock and Pre-Funded Warrants
Corp. Announces Proposed Offering of Common Stock and Pre-Funded Warrants August 10, 2022 - OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it has commenced
Read more →KIDSOrthoPediatrics Corp. Reports Second Quarter 2022 Financial Results and Increases 2022 Revenue Guidance
Second Quarter 2022 Record Revenue Increased 23% Year-over-Year Second Quarter 2022 Record Adjusted EBITDA of $2.1 million WARSAW, Ind., Aug. 03, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on
Read more →KIDSOrthoPediatrics Corp. to Report Second Quarter 2022 Financial Results on August 4, 2022
WARSAW, Ind., July 21, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its second quarter 2022 financial resu
Read more →KIDSOrthoPediatrics Corp. Announces Distribution Agreement with 3D-Side
WARSAW, Ind., July 13, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced an exclusive distribution agreement with 3D-Side S.A., a Belgi
Read more →KIDSOrthoPediatrics Corp. Completes Acquisition of Pega Medical
WARSAW, Ind., July 05, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that it has completed the previously announced acquisition of
Read more →KIDSOrthoPediatrics Corp. Announces Deal to Acquire Pega Medical Expands portfolio of trauma and deformity systems for pediatric orthopedics, including the Fassier-Duval Telescopic IM System
OrthoPediatrics Corp. Announces Deal to Acquire Expands portfolio of trauma and deformity systems for pediatric orthopedics, including the Fassier-Duval Telescopic IM System WARSAW, Indiana, June 14, 2022 - OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (Nasdaq: K
Read more →KIDSOrthoPediatrics to Participate in The JMP Securities Life Sciences Conference
WARSAW, Ind., May 24, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fre
Read more →KIDSOrthoPediatrics Corp. Continues Double Diamond Sponsorship for 2022 POSNA Meeting
WARSAW, Ind., May 10, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, has continued the Company’s support for the 2022 Pediatric Orthopaedic Society of North America
Read more →KIDSOrthoPediatrics Corp. Reports First Quarter 2022 Financial Results and Increases 2022 Revenue Guidance
WARSAW, Ind., May 04, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its financial results for the first quarter ended March 31, 202
Read more →KIDSOrthoPediatrics Corp. to Report First Quarter 2022 Financial Results on May 5, 2022
WARSAW, Ind., April 18, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its first quarter 2022 financial resu
Read more →KIDSOrthoPediatrics Spotlights Award-Winning ApiFix Technology at IMAST
WARSAW, Ind., April 12, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, showcased its award-winning technology, the ApiFix® System, at the 2022 Inter
Read more →KIDSOrthoPediatrics’ ApiFix System Selected as 2022 MDEA Finalist
WARSAW, Indiana, April 06, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce that the ApiFix® System has been named a category f
Read more →KIDSOrthoPediatrics Corp. Announces Acquisition of MD Orthopaedics Expands portfolio with a patented, non-operative solution for the treatment of clubfoot
OrthoPediatrics Corp. Announces Acquisition Expands portfolio with a patented, non-operative solution for the treatment of clubfoot Indiana, April 4, 2022 - OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (Nasdaq: KIDS), a company focused exclusively on advancing t
Read more →KIDSOrthoPediatrics to Participate in the 21st Annual Needham Virtual Healthcare Conference
WARSAW, Ind., March 31, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, Fred H
Read more →KIDSOrthoPediatrics Corp. Launches PediFlex™ Advanced Interlock Clamp System
WARSAW, Ind., March 24, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced the limited launch of its new PediFlex™ Advanced Interlock Clamp Sy
Read more →KIDSOrthoPediatrics Corp. Reports Fourth Quarter and Record Full Year 2021 Financial Results
Fourth Quarter 2021 Revenue Increased 31% Year-over-Year 2021 Revenue Increased 38% Year-over-Year WARSAW, Ind., March 02, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field o
Read more →KIDSOrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 7th Annual International Children’s Spine Symposium (ICSS)
WARSAW, Ind., March 01, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, was the leading sponsor of the 7th Annual International Children’s Spine Symposium (ICSS), whi
Read more →KIDSOrthoPediatrics Corp. Named One of the 2022 Best Places to Work in Indiana
WARSAW, Ind., Feb. 25, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, today announced it was recently named one of the 2022 Best Places to Work in I
Read more →KIDSOrthoPediatrics Corp. Celebrates 1,000th Case with FIREFLY Pedicle Screw Navigation Guides
WARSAW, Ind., Feb. 23, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced the 1,000th case performed with the FIREFLY® Pedicle Screw Navigatio
Read more →KIDSOrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022
WARSAW, Ind., Feb. 01, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its fourth quarter and full year 2021
Read more →KIDSOrthoPediatrics Announces Preliminary Unaudited Revenue for the Fourth Quarter & Full-Year 2021
WARSAW, Ind., Jan. 10, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced preliminary unaudited revenue for the fourth quarter and full
Read more →KIDSOrthoPediatrics Corp. Continued Double-Diamond Support of International Pediatric Orthopaedic Symposium (IPOS)
WARSAW, Ind., Dec. 13, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced its continued support as a Double-Diamond sponsor of the International Pediatric Orthopaedic Symposium (I
Read more →KIDSOrthoPediatrics to Participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference
WARSAW, Ind., Nov. 22, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the release of a fireside chat webcast in connection with the
Read more →KIDSOrthoPediatrics Corp. Reports Third Quarter 2021 Financial Results
WARSAW, Ind., Nov. 03, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its financial results for the third quarter ended September 30
Read more →KIDSOrthoPediatrics to Participate in the Stifel 2021 Virtual Healthcare Conference
WARSAW, Ind., Oct. 26, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, Fred Hi
Read more →KIDSOrthoPediatrics Corp. Recognized in COVID Stops Here Campaign
WARSAW, Ind., Oct. 18, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it has been awarded a Silver metal designation as part of the
Read more →KIDSOrthoPediatrics Corp. Announces Preliminary Unaudited Revenue for the Third Quarter 2021 and Reiterates 2021 Revenue Guidance
WARSAW, Indiana, Oct. 13, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced preliminary revenue for the third quarter ended September 3
Read more →KIDSOrthoPediatrics Corp. Continues Support of Autumn Surgical Society Meetings
WARSAW, Ind., Oct. 04, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its continued support for the American Academy for Cerebral Pa
Read more →KIDSOrthoPediatrics Announces Entry into a Distribution Agreement with SeaSpine to Exclusively Distribute the 7D Surgical FLASH Navigation Platform for Pediatric Applications
WARSAW, Ind., Sept. 09, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced they have entered into a distribution agreement with SeaSpine
Read more →KIDSOrthoPediatrics Corp. and Mighty Oak Medical Extend Exclusive Partnership for FIREFLY Technology in Pediatric Orthopedics
WARSAW, Ind., Aug. 04, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), and Mighty Oak Medical, Inc. are pleased to announce the continuation of their navigation partnership, extending its current five-year deal another five year
Read more →KIDSOrthoPediatrics Corp. Reports Second Quarter 2021 Financial Results
WARSAW, Ind., Aug. 04, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its financial results for the second quarter ended June 30, 20
Read more →KIDSOrthoPediatrics Corp. Maintains its Diamond Sponsorship for 31st Annual Baltimore Limb Deformity Course (“BLDC”)
WARSAW, Ind., July 29, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its continued Diamond sponsorship for the 31st Annual Baltimor
Read more →KIDSOrthoPediatrics Corp. to Report Second Quarter 2021 Financial Results on August 5, 2021
WARSAW, Ind., July 22, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its second quarter 2021 financial resu
Read more →KIDSOrthoPediatrics Corp. Announces Launch of Next Generation Cannulated Screw System
WARSAW, Ind., June 10, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today the launch of its 6.5mm/7.3mm Slipped Capital Femoral Epiphysis (“SCFE”) Cannul
Read more →KIDSOrthoPediatrics Corp. to Present at the 2021 JMP Securities Life Sciences Conference
WARSAW, Ind., June 09, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, Chief Executive Officer, Fred Hite, Chief Op
Read more →KIDSOrthoPediatrics Corp. Completes Senior Leadership Transition with Appointment of David Bailey as Chief Executive Officer
WARSAW, Ind., June 03, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the completion of the senior leadership transition, with David Bailey succeedin
Read more →KIDSOrthoPediatrics Corp. Launches RESPONSE™ Neuromuscular Scoliosis System
WARSAW, Ind., May 28, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced the launch of its RESPONSE™ Neuromuscular Scoliosis System. This will be the 36th surg
Read more →KIDSOrthoPediatrics Corp. Continues Double Diamond Sponsorship for 2021 POSNA Meeting
WARSAW, Ind., May 17, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, has continued the Company’s support for the 2021 Pediatric Orthopaedic Society of North America
Read more →KIDSOrthoPediatrics Corp. Reports First Quarter 2021 Financial Results
WARSAW, Indiana, May 05, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its financial results for the first quarter ended March 31,
Read more →KIDSOrthoPediatrics Corp. to Participate in the 7th Annual Truist Securities 2021 Life Sciences Summit
WARSAW, Ind., April 22, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President, Fred Hite, Chief Operating Office
Read more →KIDSOrthoPediatrics Corp. to Report First Quarter 2021 Financial Results on May 5, 2021
WARSAW, Ind., April 21, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its first quarter 2021 financial resu
Read more →KIDSOrthoPediatrics Corp. to Participate in the 20th Annual Needham Virtual Healthcare Conference
WARSAW, Ind., March 31, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President, Fred Hite, Chief Operating Office
Read more →KIDSOrthoPediatrics Surpasses Milestones of 500 Scoliosis Correction Cases Worldwide and Nine-Years of Clinical Experience with the ApiFix Procedure
WARSAW, Ind., March 23, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that it has surpassed two significant procedure milestones for
Read more →KIDSOrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2020 Financial Results
Full year 2020 revenue of $71.1m compared to full year 2019 revenue of $72.6m, reflecting the impact of COVID-19 on elective surgeries Guidance for full year 2021 sales growth in the range of 31-38%, reaching $93-98 million WARSAW, Ind., March 10, 2021 (GLOBE NEWSWIRE) -- Ortho
Read more →KIDSOrthoPediatrics Corp. Crosses Milestone Treating 200,000 Children with Orthopedic Conditions
WARSAW, Ind., March 04, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, today announced that as of March 2021, it estimates over 200,000 children with orthopedic cond
Read more →KIDSOrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2020 Financial Results on March 10, 2021
WARSAW, Ind., March 03, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its fourth quarter and full year 2020
Read more →KIDSOrthoPediatrics Corp. Launches Dedicated ApiFix Website to Support Game-Changing Spinal Deformity Correction System for Treating AIS
WARSAW, Ind., Feb. 18, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics and which has expanded its operating reach over the last year to serve more chil
Read more →KIDSOrthoPediatrics Corp. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
WARSAW, Ind., Feb. 11, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President, Fred Hite, Chief Operating Officer
Read more →KIDSORTHOPEDIATRICS CORPORATION INVESTOR ALERT: Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In OrthoPediatrics Corporation To Contact Him Directly To Discuss Their Options
NEW YORK, Jan. 23, 2021 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading minority and certified woman-owned national securities law firm, is investigating potential violations of the federal securities laws against OrthoPediatrics Corporation (“OrthoPediatrics or the “Company”
Read more →KIDSOrthoPediatrics Corp. Introduces Orthex in Australia
WARSAW, Ind., Jan. 22, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, continues to expand their product offering in Australia and New Zealand. Within the past 12 mon
Read more →KIDSOrthoPediatrics Corp. Introduces Expanded Product Portfolio in Canada
WARSAW, Ind., Jan. 19, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, has obtained 14 product registrations in Canada over the past 12 months. This list includes thr
Read more →KIDSOrthoPediatrics Corp. Expands its Agent Network in Three Strategic European Countries
WARSAW, Ind., Jan. 15, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its agent network in Germany, Austria and Swi
Read more →KIDSOrthoPediatrics Corp. Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2020
WARSAW, Ind., Jan. 11, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its preliminary unaudited revenue for the fourth quarter and f
Read more →KIDSOrthoPediatrics Corp. Launches Sterile Implants for PNP|FEMUR System
WARSAW, Indiana, Jan. 05, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced the 510(k) approval, and limited U.S. launch of its first sterile-packed implants
Read more →KIDSOrthoPediatrics Corp. to Participate in the 23rd Annual Needham Virtual Growth Conference
WARSAW, Ind., Jan. 04, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Mark Throdahl, Chief Executive Officer, Fred Hite, Chief O
Read more →KIDSOrthoPediatrics, Corp. Investors: Company Investigated by the Portnoy Law Firm
LOS ANGELES, Jan. 04, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises OrthoPediatrics, Corp. ("OrthoPediatrics" or the "Company") (NASDAQ: KIDS) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of
Read more →KIDSOrthoPediatrics Corp. Announces First PNP|FEMUR Case Performed in the United Kingdom
WARSAW, Ind., Dec. 29, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, today announced the first surgery in the United Kingdom utilizing the new Pediatric Nailing Pla
Read more →KIDSOrthoPediatrics Corp. Announces International Expansion in the United Kingdom
WARSAW, Ind., Dec. 21, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its expansion into the U.K. commercial market with the approva
Read more →KIDSORTHOPEDIATRICS ALERT: Bragar Eagel & Squire, P.C. is Investigating OrthoPediatrics Corp. on Behalf of OrthoPediatrics Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against OrthoPediatrics Corp. (NASDAQ: KIDS) on behalf of OrthoPediatrics stockholders. Our investigation concerns wheth
Read more →KIDSOrthoPediatrics Named 2020 Corporate Champion of the Year By World Pediatric Project
WARSAW, Ind., Dec. 03, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a Company focused exclusively on advancing the field of pediatric orthopedics, announced today that the World Pediatric Project (“WPP”) has named OrthoPediatr
Read more →KIDSOrthoPediatrics Corp. Reports Third Quarter 2020 Financial Results
WARSAW, Indiana, Nov. 04, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a Company focused exclusively on advancing the field of pediatric orthopedics, announced today its financial results for the third quarter ended September
Read more →KIDSOrthoPediatrics Corp. to Present at Four Upcoming Investor Conferences in November and December
WARSAW, Ind., Oct. 29, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Mark Throdahl, Chief Executive Officer, Fred Hite, Chief O
Read more →KIDSOrthoPediatrics Corp. to Report Third Quarter 2020 Financial Results on November 4, 2020
WARSAW, Ind., Oct. 21, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its third quarter 2020 financial resul
Read more →KIDSOrthoPediatrics Corp. to Support the 3rd Annual PediOrtho WEST Resident Education Course in October 2020
WARSAW, Ind., Oct. 08, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its continued support for the 3rd Annual PediOrtho WEST Reside
Read more →KIDSOrthoPediatrics Corp. to Sponsor Two Medical Meetings in September 2020
WARSAW, Ind., Sept. 09, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its continued support for the Scoliosis Research Society (“SR
Read more →KIDSOrthoPediatrics Corp. to Participate in the Morgan Stanley 18th Annual Global Healthcare Conference
WARSAW, Ind., Sept. 08, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Mark Throdahl, Chief Executive Officer, Fred Hite, Chief
Read more →KIDSOrthoPediatrics Corp. Announces 1,000th Procedure Utilizing its Innovative Pediatric Nailing Platform | FEMUR (“PNP | FEMUR”) System, the First Pediatric-Specific Solution Optimized to Treat Fractures and Deformities
WARSAW, Ind., Sept. 03, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced completion of the 1,000th surgery utilizing its Pediatric Nai
Read more →KIDSOrthoPediatrics Corp. Maintains its Diamond Sponsorship for Virtual 30th Annual Baltimore Limb Deformity Course (“BLDC”)
WARSAW, Ind., Aug. 24, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its continued Diamond sponsorship for the virtual 30th Annual B
Read more →KIDSOrthoPediatrics Corp. to Participate in the 5th Annual Needham Virtual Med Tech 1x1 Conference
WARSAW, Ind., Aug. 10, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Mark Throdahl, Chief Executive Officer, Fred Hite, Chief O
Read more →KIDSOrthoPediatrics Corp. Reports Second Quarter 2020 Financial Results
WARSAW, Ind., Aug. 05, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its financial results for the second quarter ended June 30, 202
Read more →KIDSOrthoPediatrics Corp. Achieves 500th Case with FIREFLY Pedicle Screw Navigation Guides
WARSAW, Ind., Aug. 03, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced the 500th case performed with the FIREFLY® Pedicle Screw Navigation
Read more →KIDSOrthoPediatrics Corp. to Report Second Quarter 2020 Financial Results on August 5, 2020
WARSAW, Ind., July 23, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its second quarter 2020 financial resu
Read more →KIDSOrthoPediatrics Corp. Announces Closing of Offering of Common Stock
WARSAW, Ind., June 22, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (Nasdaq: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the closing of its underwritten public offering of 1,600,000 shares of its comm
Read more →KIDSOrthoPediatrics Corp. Announces Pricing of Offering of Common Stock
WARSAW, Ind., June 18, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (Nasdaq: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the pricing of its underwritten public offering of 1,600,000 shares of its comm
Read more →KIDSOrthoPediatrics Corp. Announces Proposed Public Offering of Common Stock
OrthoPediatrics Corp. Announces Proposed Public Offering of Common Stock WARSAW, Indiana, June 17, 2020 - OrthoPediatrics Corp. ("OrthoPediatrics") (Nasdaq: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that it is commen
Read more →KIDSOrthoPediatrics Corp. Commences Initial U.S. Launch of ApiFix’s FDA-Approved Spinal Deformity Correction System
WARSAW, Ind., June 10, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, is pleased to announce the initial U.S. launch of the ApiFix Minimally Invasive
Read more →KIDSOrthoPediatrics Corp. to Continue Sponsorship for 2020 POSNA Annual Meeting
WARSAW, Ind., May 13, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced the Company’s continued Double-Diamond sponsorship for the virtual 202
Read more →KIDSOrthoPediatrics Corp. Reports First Quarter 2020 Financial Results
WARSAW, Ind., May 05, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its financial results for the first quarter ended March 31, 2020
Read more →KIDSOrthoPediatrics Corp. to Participate in the 6th Annual SunTrust Robinson Humphrey Life Sciences Summit
WARSAW, Ind., April 29, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Mark Throdahl, President & Chief Executive Officer, Fred
Read more →KIDSOrthoPediatrics Corp. to Report First Quarter 2020 Financial Results on May 5, 2020
WARSAW, Ind., April 21, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its first quarter 2020 financial resu
Read more →KIDSOrthoPediatrics Corp. Announces Acquisition of ApiFix Ltd. with FDA-Approved Non-Fusion Scoliosis Technology
Expands portfolio of spinal deformity systems with unique, less invasive, non-fusion surgical solution for progressive adolescent idiopathic scoliosis Company to host a conference call tomorrow April 2 at 8:30am ET WARSAW, Ind., April 01, 2020 (GLOBE NEWSWIRE) -- OrthoPediatric
Read more →KIDSOrthoPediatrics Corp.
OrthoPediatrics Corp. Announces Acquisition of ApiFix Ltd. with FDA-Approved Non-Fusion Scoliosis Technology Expands portfolio of spinal deformity systems with unique, less invasive, non-fusion surgical solution for progressive adolescent idiopathic scoliosis Company to host
Read more →KIDSOrthoPediatrics Corp. Receives FDA 510(k) Clearance and Expanded Neuromuscular Indications for its RESPONSE™ Scoliosis System
WARSAW, Ind., March 31, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to
Read more →KIDSOrthoPediatrics Corp. Provides COVID-19 Business Update
WARSAW, Ind., March 30, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today provided a business update on the proactive steps it is taking in respo
Read more →KIDSOrthoPediatrics Corp. Announces U.S. Launch of Large Fragment Cannulated Screw System
WARSAW, Ind., March 09, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, is pleased to announce the limited U.S. launch of its Large Fragment Cannulat
Read more →KIDSOrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2019 Financial Results
Consecutive year of record annual revenue with 26.0% year-over-year growth to $72.6 million Full year 2020 revenue growth guidance in the range of 22% to 24% WARSAW, Ind., March 04, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS
Read more →KIDSOrthoPediatrics Corp. Announces Direct Sales Agency Expansion in Italy
WARSAW, Ind., March 03, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, today announced an updated agreement with Medical 2011 S.r.l. (“Medical 2011”) to act as Ortho
Read more →KIDSOrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 6th Annual International Children’s Spine Symposium (ICSS)
WARSAW, Ind., March 02, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it will attend the 6th Annual International Children’s Spine Symposium (ICSS),
Read more →KIDSOrthoPediatrics Corp. Continues to be Honored as One of the Best Place to Work in Indiana
WARSAW, Ind., Feb. 26, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce that it was recently named one of the Best Places to Work in Indiana by the Indiana Chamber
Read more →KIDSOrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2019 Financial Results on March 4, 2020
WARSAW, Ind., Feb. 18, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its fourth quarter and full year 2019
Read more →KIDSOrthoPediatrics Corp. Reports Preliminary Unaudited Revenue for Fourth Quarter and Record Setting Full Year 2019
WARSAW, Ind., Jan. 13, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its preliminary unaudited revenue for the fourth quarter and full year ended De
Read more →KIDSOrthoPediatrics Corp. Announces Divestiture of the Vilex Adult Business
OrthoPediatrics Corp. Announces Divestiture of the Vilex Adult Business WARSAW, Indiana, January 6, 2020 - OrthoPediatrics Corp. ("OrthoPediatrics") (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that it has comp
Read more →KIDSOrthoPediatrics Corp. Announces U.S. Launch of QuickPack™
WARSAW, Ind., Dec. 20, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, is pleased to announce the U.S. launch of QuickPack™, a fully synthetic bone graft substitute f
Read more →KIDSOrthoPediatrics Corp. Announces Closing of Common Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
WARSAW, Ind., Dec. 17, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today the closing of its underwritten follow-on public offering of 1,805,500 shares o
Read more →KIDSOrthoPediatrics Corp. to Sponsor the Annual International Pediatric Orthopaedic Symposium (IPOS)
The Company will sponsor a pre-course meeting in addition to five spotlight sessions on a variety of topics WARSAW, Ind., Nov. 20, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announc
Read more →KIDSOrthoPediatrics Corp. Announces U.S. Launch of PediFoot Deformity Correction System
WARSAW, Ind., Nov. 15, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, is pleased to announce the domestic launch of the PediFoot Deformity Correction System (“PediFo
Read more →KIDSOrthoPediatrics Corp. to Present at Two Upcoming Investor Conferences
WARSAW, Ind., Nov. 11, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), an orthopedic company focused exclusively on advancing the field of pediatric orthopedics, announced today that Mark Throdahl, President & Chief Executive Officer, and Fred Hi
Read more →KIDSOrthoPediatrics Corp. Reports Third Quarter 2019 Financial Results
Record quarterly revenue of $20.7 million, up 31.1% year-over-year WARSAW, Ind., Nov. 07, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its financia
Read more →KIDSOrthoPediatrics Corp. to Report Third Quarter 2019 Financial Results on November 7, 2019
WARSAW, Ind., Oct. 23, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its third quarter 2019 financial resul
Read more →KIDSOrthoPediatrics Corp. to Participate at the Cantor Fitzgerald Global Healthcare Conference
WARSAW, Ind., Sept. 25, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), an orthopedic company focused exclusively on advancing the field of pediatric orthopedics, announced today that Mark Throdahl, President & Chief Executive Officer, and Dave B
Read more →KIDSOrthoPediatrics Corp. to Sponsor Three Medical Meetings in September 2019
WARSAW, Ind., Sept. 16, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today it will continue its support as a Platinum Level Sponsor for the 73rd Annual M
Read more →KIDSOrthoPediatrics Corp. Announces U.S. Launch of Next Generation Cannulated Screw Systems
WARSAW, Indiana, Sept. 09, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, is pleased to announce the U.S. launch of the next generation Cannulated Screw Systems for
Read more →KIDSa123117123118v Vilex in Tennessee, Inc. and Affiliate Combined Financial Statements Years Ended
Vilex in Tennessee, Inc. and Affiliate Combined Financial Statements Years Ended December 31, 2018 and 2017 Independent Auditor's Report Board of Directors Vilex in Tennessee, Inc. and Affiliate McMinnville, Tennessee Report on the Combined Financial Statements We have audited t
Read more →KIDSOrthoPediatrics Corp. Receives FDA 510(k) Clearance for First Pediatric-Specific Foot System
WARSAW, Ind., Aug. 19, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FD
Read more →KIDSOrthoPediatrics Corp. Reports Second Quarter 2019 Financial Results
WARSAW, Ind., Aug. 07, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its financial results for the quarter ended June 30, 2019. Second Quarter & Rec
Read more →KIDSOrthoPediatrics Corp. to Participate in 4th Annual Needham Med Tech & Diagnostics Conference
WARSAW, Ind., Aug. 05, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that Mark Throdahl, President & Chief Executive Officer, and Fred Hite, Chief F
Read more →KIDSOrthoPediatrics Corp. to Report Second Quarter 2019 Financial Results on August 7, 2019
WARSAW, Ind., Aug. 02, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its second quarter 2019 financial resul
Read more →KIDSOrthoPediatrics Corp. Receives FDA 510(k) Clearance for Next Generation Cannulated Screw System
WARSAW, Ind., July 23, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FD
Read more →KIDSOrthoPediatrics Corp. to Sponsor 26th Annual International Meeting on Advanced Spine Techniques (IMAST)
WARSAW, Ind., July 03, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today it will continue its support as a Gold Level sponsor for the 26th Annual Intern
Read more →KIDSOrthoPediatrics Corp. to Present at the JMP Life Sciences Conference
WARSAW, Ind., June 10, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), an orthopedic company focused exclusively on advancing the field of pediatric orthopedics, announced today that Mark Throdahl, President & Chief Executive Officer, is schedule
Read more →KIDSOrthoPediatrics Corp. June, 2019 Mark Throdahl , CEO Fred Hite, CFO Disclaimer Forward - Looking Statements This presentation includes "forward - looking statements" within the meaning of U . S . federal securities laws
OrthoPediatrics Corp. June, 2019 Mark Throdahl , CEO Fred Hite, CFO Disclaimer Forward - Looking Statements This presentation includes "forward - looking statements" within the meaning of U . S . federal securities laws . You can identify forward - looking statements by the use
Read more →KIDSOrthoPediatrics Announces Acquisition of Vilex and Novel External Fixation Technology The Company to host conference call today at 8:30am
OrthoPediatrics Announces Acquisition of Vilex and Novel External Fixation Technology The Company to host conference call today WARSAW, Indiana, June 5, 2019 - OrthoPediatrics Corp. ("OrthoPediatrics") (NASDAQ:KIDS), a company focused exclusively on advancing the field of ped
Read more →KIDSOrthoPediatrics Corp. to Continue Sponsorship for 2019 POSNA Meeting
WARSAW, Ind., May 15, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), an orthopedic company focused exclusively on advancing the field of pediatric orthopedics, today announced the Company’s continued sponsorship for the 2019 Pediatric Orthopaedi
Read more →KIDSOrthoPediatrics Corp. Reports First Quarter 2019 Financial Results
WARSAW, Ind., May 08, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), an orthopedic company focused exclusively on advancing the field of pediatric orthopedics, today announced financial results for the first quarter ended March 31, 2019. First
Read more →KIDSOrthoPediatrics Corp. to Report First Quarter 2019 Financial Results on May 8, 2019
WARSAW, Ind., April 29, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), an orthopedic company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its first quarter 2019 fin
Read more →KIDSOrthoPediatrics Corp. Announces Licensing Partnership with CoorsTek Medical
WARSAW, Ind., April 22, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce a sublicense agreement with CoorsTek Medical for rights to its Variable
Read more →KIDSOrthoPediatrics Corp. to Sponsor 38th Annual European Paediatric Orthopaedic Society (EPOS) Meeting and Lunch Symposium
WARSAW, Ind., April 03, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today it will continue its support as the sole Diamond sponsor for the 38th Annual E
Read more →KIDSOrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2018 Financial Results
WARSAW, Indiana, March 06, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today its financial results for the fourth quarter and full year ended December 31, 2018. Fourth Quar
Read more →KIDSOrthoPediatrics Corp. to Participate at The Canaccord Genuity 2019 Musculoskeletal Conference
WARSAW, Ind., March 04, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that Mark Throdahl, President & Chief Executive Officer, Fred Hite, Chief Financial Officer, and Da
Read more →KIDSOrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2018 Financial Results on March 6, 2019
WARSAW, Indiana, Feb. 25, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market, announced today that the Company is scheduled to
Read more →KIDSOrthoPediatrics Corp. Announces Global Launch of New BandLoc DUO
WARSAW, Ind., Feb. 25, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce the launch of BandLoc DUO, the latest enhancement to the BandLoc 5.5/6.0
Read more →KIDSOrthoPediatrics Corp. Honored as One of the Best Place to Work in Indiana for a Third Year
WARSAW, Ind., Feb. 22, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce that it was recently named as one of the Best Places to Work in Indiana by the Indiana Chamb
Read more →KIDSOrthoPediatrics Corp. to Participate in BTIG Healthcare Conference
WARSAW, Ind., Feb. 20, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that Mark Throdahl, President & Chief Executive Officer, and Fred Hite, Chief F
Read more →KIDSOrthoPediatrics Corp. Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2018
WARSAW, Ind., Jan. 07, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today its preliminary unaudited revenue for the fourth quarter and full year ended December 31, 2018. Pr
Read more →KIDSOrthoPediatrics Corp. Announces Direct Sales Agency Expansion in Belgium and the Netherlands
WARSAW, Ind., Jan. 04, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today their recently updated and signed agreement with Hospithera to act as OrthoPedi
Read more →KIDSOrthoPediatrics Corp. Files Sanctions Motion Against a Former Employee and WishBone Medical, Inc.
WARSAW, Indiana, Jan. 02, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, today issued a statement from Daniel Gerritzen, Vice President and General Counsel, concerni
Read more →KIDSOrthoPediatrics Corp. Announces Full-Scale U.S. Launch of Small Stature Scoliosis System
WARSAW, Ind., Dec. 13, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the full-scale U.S. launch of its 26th surgical system, the RESPONSE 4.5/5.0mm System following U.S
Read more →KIDSOrthoPediatrics Corp. Announces Proposed Offering of Common Stock
WARSAW, Ind., Dec. 06, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (Nasdaq: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that it is commencing an underwritten follow-on public offering of its common s
Read more →KIDSOrthoPediatrics Corp. Enhances Product Offering with Upgraded PediLoc Femur Plate System
WARSAW, Ind., Nov. 27, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the U.S. launch of its new PediLoc® Femur Plate System. Building on the success of the existing Pe
Read more →KIDSOrthoPediatrics Corp. to Participate in Two Upcoming Conferences
WARSAW, Ind., Nov. 05, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that Mark Throdahl, President & Chief Executive Officer, and Fred Hite, Chief Financial Officer, are
Read more →KIDSOrthoPediatrics Corp. Reports Third Quarter 2018 Financial Results
Third Quarter 2018 Revenue Increased 27.8% Year-over-Year to $15.8 Million Full Year 2018 Revenue Growth Guidance Increased to a Range of 25.0% to 25.5% WARSAW, Ind., Oct. 31, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advanc
Read more →KIDSOrthoPediatrics Corp. to Report Third Quarter 2018 Financial Results on October 31, 2018
Conference Call to Discuss Results on November 1, 2018 at 8:00 a.m. ET WARSAW, Ind., Oct. 24, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatri
Read more →KIDSOrthoPediatrics Corp. Receives FDA 510(k) Clearance for Small Stature Scoliosis System with 26th Surgical System
WARSAW, Ind., Oct. 19, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new RESPO
Read more →KIDSOrthoPediatrics Corp. to Sponsor Two Medical Meetings in October
WARSAW, Ind., Sept. 27, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today it will continue its Premier sponsorship for the 72nd Annual Meeting of the American Academy for C
Read more →KIDSOrthoPediatrics Corp. Announces First PNP | FEMUR Cases Performed in Australia
WARSAW, Ind., Sept. 17, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce the first surgeries in Australia utilizing the new Pediatric Nailing Pl
Read more →KIDSOrthoPediatrics Corp. to Participate at the Morgan Stanley 16th Annual Global Healthcare Conference
WARSAW, Ind., Sept. 04, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that Mark Throdahl, President & Chief Executive Officer, and Fred Hite, Chief Financial Officer, ar
Read more →KIDSOrthoPediatrics Corp. Announces Expansion of its Warsaw Headquarters
WARSAW, Ind., Aug. 14, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the expansion of its Warsaw, Indiana headquarters. The planned $1M expansion will double the Company
Read more →KIDSOrthoPediatrics Corp. to Present at FDA Conference on Pediatric Devices
WARSAW, Ind., Aug. 10, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to participate in the Pediatric Medical Device Development Public Meeting, organized by the U.S. Food & D
Read more →KIDSOrthoPediatrics Corp. Reports Second Quarter 2018 Financial Results
WARSAW, Ind., Aug. 08, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today its financial results for the second quarter ended June 30, 2018. Second Quarter & Recent Highlight
Read more →KIDSOrthoPediatrics Announces Expanded Indication for FIREFLY Pedicle Screw Navigation Guides
WARSAW, Ind., July 31, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce that FIREFLY® Pedicle Screw Navigation Guides (“FIREFLY”) received additional FDA 510(k) clea
Read more →KIDSOrthoPediatrics Corp. to Report Second Quarter 2018 Financial Results on August 8, 2018
WARSAW, Ind., July 25, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market, announced today that the Company is scheduled to re
Read more →KIDSOrthoPediatrics Corp. Announces Full Launch of Pediatric Nailing Platform | FEMUR
WARSAW, Ind., July 11, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the full-scale launch of the Pediatric Nailing Platform|FEMUR (“PNP|FEMUR”), Ort
Read more →KIDSOrthoPediatrics Corp. Announces First RESPONSE Spine Surgery Performed in Japan
WARSAW, Ind., June 18, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce the first spine surgery in Japan utilizing the RESPONSE™ Spine System (“R
Read more →KIDSOrthoPediatrics Corp. Announces First Surgery Performed with Pediatric Nailing Platform | FEMUR
WARSAW, Ind., June 04, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the first surgery utilizing OrthoPediatrics’ newly launched rigid intramedullary
Read more →KIDSOrthoPediatrics Corp. to Present at Jefferies & William Blair Healthcare Conferences
WARSAW, Ind., May 24, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that Mark Throdahl, President & Chief Executive Officer, and Fred Hite, Chief Fin
Read more →KIDSOrthoPediatrics Corp. Announces FDA 510(k) Clearance for its 25th Surgical System, Pediatric Nailing Platform |FEMUR
WARSAW, Ind., May 14, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce U.S. Food and Drug Administration (FDA) 510k clearance for the Pediatric Nailing Platform | FE
Read more →KIDSOrthoPediatrics Corp. Reports First Quarter 2018 Financial Results
WARSAW, Ind., May 14, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today its financial results for the first quarter ended March 31, 2018. First Quarter & Recent Highlights
Read more →KIDSOrthoPediatrics Supports Third Medical Mission with World Pediatric Project
WARSAW, Ind., May 10, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, recently participated in the Company’s third medical mission with World Pediatric Project (WPP), a foundation focused
Read more →KIDSOrthoPediatrics is a Double Diamond Sponsor for 2018 POSNA Meeting
WARSAW, Ind., May 07, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, today announced its ongoing support as a Double Diamond sponsor for the 2018 Pediatric Orthopedic Society of North Am
Read more →KIDSOrthoPediatrics Corp. to Report First Quarter 2018 Financial Results on May 14, 2018
WARSAW, Ind., April 23, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market, announced today that the Company is scheduled to r
Read more →KIDSOrthoPediatrics Corp. Honored as One of the Best Places to Work in Indiana for a Second Year
WARSAW, Ind., April 16, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce that it was recently named as one of the Best Places to Work in Indiana by the Indiana Chamb
Read more →KIDSOrthoPediatrics Corp. Announces Sponsorship of 2018 EPOS Meeting and Lunch Symposium
WARSAW, Ind., April 09, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, today announced it will continue its Diamond sponsorship for the 37th Annual European Paediatric Orthopaedic Societ
Read more →KIDSOrthoPediatrics Corp. Introduces PediFlex™ Advanced Surgical System
WARSAW, Ind., March 22, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce the introduction of PediFlex™ Advanced, the Company’s next generation elastic nailing platfo
Read more →KIDSOrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2017 Financial Results
WARSAW, Ind., March 07, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today its financial results for the fourth quarter and full year ended December 31, 2017. Fourth Quarter
Read more →KIDSOrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2017 Financial Results on March 7, 2018
WARSAW, Ind., Feb. 27, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market, announced today that the Company is scheduled to release its fourth qua
Read more →KIDSOrthoPediatrics Corp. to Participate in Canaccord Genuity’s Musculoskeletal Conference
WARSAW, Ind., Feb. 20, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market, announced today that Mark Throdahl, President & Chief Executive Officer
Read more →KIDSOrthoPediatrics Corp. Announces Preliminary Revenue for Fourth Quarter and Full Year 2017
WARSAW, Ind., Jan. 05, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today its preliminary unaudited revenue for the fourth quarter and full year ended Dec
Read more →KIDSOrthoPediatrics Corp. Expands PediPlates Franchise with Titanium System
WARSAW, Ind., Jan. 03, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce the launch of Titanium PediPlates®, the Company’s 24th surgical system. The titanium implant
Read more →KIDSOrthoPediatrics Corp. Appoints Samuel D. Riccitelli to its Board of Directors
WARSAW, Ind., Dec. 15, 2017 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the appointment of Samuel D. Riccitelli to its Board of Directors as an independ
Read more →KIDSOrthoPediatrics Corp. Launches New Wrist Fusion Plate System
WARSAW, Ind., Dec. 11, 2017 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce the launch of its pediatric-specific Wrist Fusion Plate System. This plating system is the ne
Read more →KIDSOrthoPediatrics Corp. to Highlight its Products at the 14th Annual International Pediatric Orthopaedic Symposium
WARSAW, Ind., Nov. 27, 2017 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that it is a Platinum sponsor of the 14th Annual International Pediatric Orthopa
Read more →KIDSOrthoPediatrics Corp. to Participate in the 29th Annual Piper Jaffray Healthcare Conference
WARSAW, Ind., Nov. 16, 2017 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that Mark Throdahl, President & Chief Executive Officer, and Fred Hite, Chief Fi
Read more →KIDSOrthoPediatrics Corp. to Start Distributing Bioretec Devices via Private Label
WARSAW, Ind., Nov. 13, 2017 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, and Bioretec Ltd. (“Bioretec”), announced today that they have amended their existing distributi
Read more →KIDSOrthoPediatrics Corp. to Present at Stifel 2017 Healthcare Conference
WARSAW, Ind., Nov. 10, 2017 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that Mark Throdahl, President & Chief Executive Officer, and Fred Hite, Chief Fi
Read more →KIDSOrthoPediatrics Corp. Reports Third Quarter 2017 Financial Results
WARSAW, Ind., Nov. 08, 2017 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today its financial results for the third quarter ended September 30, 2017. Third Qua
Read more →KIDSOrthoPediatrics Corp. to Report Third Quarter 2017 Financial Results on November 8, 2017
WARSAW, Ind., Oct. 30, 2017 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market, announced today that the Company plans to release i
Read more →KIDSOrthoPediatrics Corp. Announces Closing of $59.8 Million Initial Public Offering WARSAW, IN
OrthoPediatrics Corp. Announces Closing of $59.8 Million Initial Public Offering WARSAW, IN, October 16, 2017 (GLOBE NEWSWIRE) - OrthoPediatrics Corp. (NASDAQ: KIDS), an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orth
Read more →KIDSOrthoPediatrics Corp. (Nasdaq: KIDS) to Ring The Nasdaq Stock Market Opening Bell in Celebration of Its IPO
ADVISORY, Oct. 13, 2017 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (Nasdaq:KIDS), the only orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions, will vis
Read more →KIDSOrthoPediatrics Corp. Announces Pricing of Initial Public Offering
WARSAW, Ind., Oct. 12, 2017 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”), an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market, announced today the pricing of its initial public offering of 4,0
Read more →KIDSOrthoPediatrics Corp. Announces Launch of Initial Public Offering
WARSAW, Ind., Oct. 02, 2017 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”), an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market, announced today the launch of the initial public offering of 4,00
Read more →KIDSOrthoPediatrics Corp. Files Amendment to Registration Statement for Proposed Initial Public Offering
WARSAW, Ind., Sept. 11, 2017 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) announced today that it has publicly filed an amendment to its registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to a proposed initial
Read more →KIDSOrthoPediatrics and Mighty Oak Medical Team Up to Bring Pediatric-Friendly Spinal Navigation to Children’s Hospitals
WARSAW, Ind., Aug. 28, 2017 (GLOBE NEWSWIRE) -- OrthoPediatrics and Mighty Oak Medical are pleased to announce a navigation partnership that can provide unsurpassed screw placement accuracy in the pediatric population. Mighty Oak Medical is the manufacturer of FIREFLY® Pedicle S
Read more →KIDSOrthoPediatrics Corp. Files Registration Statement for Proposed Initial Public Offering
WARSAW, Ind., Aug. 11, 2017 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) announced today that it has publicly filed an amendment to its registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to a proposed initial
Read more →Competitive Position
How KIDS ranks across every disease it competes inCompetitive Position is a premium feature
See how KIDS ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial